Our previous studies showed that increased expression of tumor-associated MDM2 short isoforms (e.g., the isoform B) and BAG2 in tumors inhibits MDM2-mediated mutp53 degradation, leading to mutp53 accumulation in tumors to promote tumorigenesis (25, 40). Here, MDM2 is linked to neoplasm.